ON Accelerate Teams
ON Accelerate is a structured accelerator program for research teams to validate and develop high potential innovative ventures. See all our teams from 2023 onwards below.
EMU Systems
At EMU Systems we have developed standalone devices that accurately monitor the key aspects of the local environment that determine health and productivity. Seeking: Pre-seed funding and like-minded partners
Plasmid Therapy
Plasmid Therapy develops novel, safe, scalable, and affordable solutions to eradicate antimicrobial resistance genes from bacterial populations without disturbing the bacteria themselves or driving resistance adaptations. Seeking: Commercial partners for market expertise
Infinite Bioworks
Infinite Bioworks pioneers the frontier of "building with biology," leveraging cutting-edge manufacturing methods to create eco-friendly products with a positive impact on our planet. Seeking: Connections with industry and like-minded investors
ErythroSight
ErythroSight is developing novel therapeutics to treat retinal diseases using the patient's own red blood cells and has shown strong preclinical results in reducing the severity of currently incurable diseases such as age-related macular degeneration. Seeking: Funding to help drive the next stages of growth
Jessie Technology
Jessie Technology is a collaboration between ACU and Microsoft, working with leading aged care providers to develop a hands-free technology solution that automates data entry. Seeking: Partnerships with investors and connections with advisors
Continuous3D
At Continuous3D, we’re creating a future where infrastructure is built and maintained with the help of robots. Seeking: Relevant connections with industry and deep-tech investors
Green Shield
Green Shield offers a class of materials that are highly adaptive and provide unique solutions for radio frequency shielding or signature management, also known as object camouflage.
WhalePOD
WhalePOD is a technology to enable a new age of industrialisation where environmental conservation and scientific contribution is an outcome of business, not a burden.
CELLWorks
The WEHI Application Development 'CELLWorks' venture will help to lower the cost, increase the efficiency, and improve the ethical treatment, of using animal models in research environments.
FytoBio
CSIRO’s FytoBio team has developed a process technology for the super-efficient and scalable production of specialised performance proteins in food-appropriate quality, quantity and cost.